Metastatic, Castration-Sensitive

Metastatic Castration-Sensitive Prostate Cancer Clinical Trial Pipeline Insights Featuring 35+ Companies | DelveInsight

07.08.2025 - 18:03:17

DelveInsight Business Research, LLP United States of America United Kingdom


+14699457679
www.delveinsight.com 

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/metastatic-castration-sensitive-prostate-cancer-clinical-trial-pipeline-insights-featuring-35-companies--delveinsight-302275916.html

@ prnewswire.co.uk
Lerne live von den Börsen-Profis – melde dich jetzt kostenlos an.